Critical Analyses of the Introduction of Liquid-Based Cytology in a Public Health Service of the State of Sao Paulo, Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
KARGER
Citação
ACTA CYTOLOGICA, v.59, n.3, p.273-277, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: The aim of this study was to compare the performance of the current conventional Pap smear with liquidbased cytology (LBC) preparations. Study Design: Women routinely undergoing their cytopathological and histopathological examinations at Fundacao Oncocentro de Sao Paulo (FOSP) were recruited for LBC. Conventional smears were analyzed from women from other areas of the State of Sao Paulo with similar sociodemographic characteristics. Results: A total of 218,594 cases were analyzed, consisting of 206,999 conventional smears and 11,595 LBC. Among the conventional smears, 3.0% were of unsatisfactory preparation; conversely, unsatisfactory LBC preparations accounted for 0.3%. The ASC-H (atypical squamous cells -cannot exclude high-grade squamous intraepithelial lesion) frequency did not demonstrate any differences between the twomethods. In contrast, the incidence of ASC-US (atypical squamous cells of undetermined significance) was almost twice as frequent between LBC and conventional smears, at 2.9 versus 1.6%, respectively. An equal percentage of highgrade squamous intraepithelial lesions were observed for the two methods, but not for low-grade squamous intraepithelial lesions, which were more significantly observed in LBC preparations than in conventional smears (2.2 vs. 0.7%). The index of positivity was importantly enhanced from 3.0% (conventional smears) to 5.7% (LBC). Conclusions : LBC performed better than conventional smears, and we are truly confident that LBC can improve public health strategies aimed at reducing cervical lesions through prevention programs. (C) 2015 S. Karger AG, Basel
Palavras-chave
Cervical cancer screening, Cytology in low-resource settings, Gynecologic cytology, Liquid-based cytology, Public health
Referências
  1. Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9
  2. Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015
  3. Arbyn M, 2008, OBSTET GYNECOL, V111, P167, DOI 10.1097/01.AOG.0000296488.85807.b3
  4. Cummings MC, 2015, CANCER CYTOPATHOL, V123, P108, DOI 10.1002/cncy.21498
  5. Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516
  6. Fregnani JHTG, 2013, ACTA CYTOL, V57, P69, DOI 10.1159/000343046
  7. INCA: ESTIMATIVA, 2014, ESTIMATIVA 2014 INC
  8. Isidean SD, 2014, LANCET, V383, P493, DOI 10.1016/S0140-6736(13)62028-0
  9. Longatto A, 2010, ACTA CYTOL, V54, P654
  10. Longatto-Filho A, 2007, DIAGN CYTOPATHOL, V35, P672, DOI 10.1002/dc.20700
  11. Longatto A, 2012, VIRCHOWS ARCH, V460, P577, DOI 10.1007/s00428-012-1242-y
  12. Lynge E, 2009, EUR J CANCER, V45, P2714, DOI 10.1016/j.ejca.2009.07.024
  13. Monsonego J, 2012, GYNECOL ONCOL, V125, P175, DOI 10.1016/j.ygyno.2012.01.002
  14. Navarro C, 2015, REV SAUDE PAILICA, V49, P1
  15. The NHS Information Centre, 2011, SCREEN IMM TEAM CERV
  16. Nygard JF, 2002, J MED SCREEN, V9, P86, DOI 10.1136/jms.9.2.86
  17. Renshaw AA, 2004, ARCH PATHOL LAB MED, V128, P17
  18. Ronco G, 2007, BRIT MED J, V335, P28, DOI 10.1136/bmj.39196.740995.BE
  19. Saieg MA, 2014, ACTA CYTOL, V58, P378, DOI 10.1159/000365944
  20. Scapulatempo C, 2013, ACTA CYTOL, V57, P489, DOI 10.1159/000351789
  21. Schmitt FC, 2008, J CLIN PATHOL, V61, P258, DOI 10.1136/jcp.2006.044347
  22. Siebers AG, 2014, CANCER CAUSE CONTROL, V25, P1141, DOI 10.1007/s10552-014-0414-2
  23. Stein MD, 2013, AM J CLIN PATHOL, V140, P567, DOI 10.1309/AJCPWL36JXMRESFH
  24. Vanni T, 2011, INT J CANCER, V129, P671, DOI 10.1002/ijc.25708
  25. Wilbur DC, 2009, AM J CLIN PATHOL, V132, P767, DOI 10.1309/AJCP8VE7AWBZCVQT
  26. Zheng BW, 2015, ARCH PATHOL LAB MED, V139, P373, DOI 10.5858/arpa.2014-0070-OA